Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN111606917B discloses a scalable synthesis of C-ring fused abietane lactones. Discover cost-effective routes for high-purity oncology intermediates.
Patent CN1532195A reveals a high-yield Olmesartan synthesis route. Discover cost-effective manufacturing strategies and supply chain advantages for this key ARB intermediate.
Advanced purification method for cefpirome sulfate ensuring high purity and stability. Cost-effective solution for pharmaceutical manufacturers seeking reliable API intermediates.
Patent CN104926671A enables high-yield D-phenylalanine production with reduced costs and superior purity for pharmaceutical supply chains globally.
Novel tin tetrachloride catalyzed route for Sofosbuvir intermediate. High yield, optical purity, scalable manufacturing solution for pharma supply chains.
Patent CN109053716B details a novel high-yield route for Metopimazine, eliminating selective oxidation bottlenecks and ensuring >99.3% purity for reliable supply chains.
Novel purification patent CN106243128A ensures 99.7% purity. Reduces isomers significantly for reliable supply chain and cost efficiency.
Patent CN119569526A enables catalyst-free photosynthesis of ortho-dihalogenated compounds using inorganic salts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109180577B introduces a superior Aripiprazole synthesis minimizing dimer impurities. Discover cost-effective manufacturing strategies for reliable API intermediate supply.
Discover the advanced synthesis of triazolo pyrimidine derivatives via selective condensation. A cost-effective, scalable solution for pharmaceutical intermediates.
Novel palladium-catalyzed route for flibanserin intermediate ensures high purity and scalable production for global pharmaceutical supply chains reducing costs significantly.
Patent CN1100035C reveals low-pressure hydrogenation for high-purity intermediates. Achieve substantial cost reduction and supply chain reliability with scalable Raney catalyst technology.
New patent CN116621710B reveals high-yield cyclopropylamine synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103555683B reveals high-purity saxagliptin intermediate synthesis via PDH mutant. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel patent CN115093392B details high-purity R-lipoic acid synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN114957103B reveals a novel Rhodium-catalyzed method for axially chiral halogenated biaryl compounds, offering superior enantioselectivity and supply chain reliability for pharmaceutical manufacturing.
Patent CN116555378A reveals a novel enzymatic method for ATP production reducing costs and ensuring stable supply chains for pharmaceutical intermediates globally.
Patent CN119431226A reveals a visible light catalytic method for beta-aryl beta-pyridyl alkyl ketones offering mild conditions and scalable supply chain advantages.
Novel synthesis route for high-purity isoxazoline derivatives offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel catalytic transfer hydrogenation method for Ticagrelor intermediate. Reduces cost and toxicity compared to borane reduction. High ee value.